CY1118079T1 - Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης - Google Patents

Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης

Info

Publication number
CY1118079T1
CY1118079T1 CY20161100993T CY161100993T CY1118079T1 CY 1118079 T1 CY1118079 T1 CY 1118079T1 CY 20161100993 T CY20161100993 T CY 20161100993T CY 161100993 T CY161100993 T CY 161100993T CY 1118079 T1 CY1118079 T1 CY 1118079T1
Authority
CY
Cyprus
Prior art keywords
preparation
arginic
perindopril salt
perindopril
salt
Prior art date
Application number
CY20161100993T
Other languages
English (en)
Inventor
Julie Linol
Stéphane Laurent
Arnaud Grenier
Sébastien Mathieu
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47427278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118079(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1118079T1 publication Critical patent/CY1118079T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μέθοδος παρασκευής της ένωσης του τύπου (Ι):
CY20161100993T 2012-01-05 2016-10-05 Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης CY1118079T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200034A FR2985512B1 (fr) 2012-01-05 2012-01-05 Procede de preparation du sel de l-arginine du perindopril

Publications (1)

Publication Number Publication Date
CY1118079T1 true CY1118079T1 (el) 2017-06-28

Family

ID=47427278

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100993T CY1118079T1 (el) 2012-01-05 2016-10-05 Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης

Country Status (46)

Country Link
US (1) US8865915B2 (el)
EP (1) EP2612851B1 (el)
JP (1) JP5722924B2 (el)
KR (1) KR101502946B1 (el)
CN (1) CN103193863B (el)
AP (1) AP2013006655A0 (el)
AR (1) AR089632A1 (el)
AU (1) AU2012268816B2 (el)
BR (1) BR102013000256B1 (el)
CA (1) CA2801089C (el)
CL (1) CL2013000022A1 (el)
CO (1) CO6700138A1 (el)
CR (1) CR20120654A (el)
CU (1) CU24293B1 (el)
CY (1) CY1118079T1 (el)
DK (1) DK2612851T3 (el)
EA (1) EA022573B1 (el)
EC (1) ECSP13012366A (el)
ES (1) ES2595236T3 (el)
FR (1) FR2985512B1 (el)
GE (1) GEP20146183B (el)
GT (1) GT201300002A (el)
HR (1) HRP20161145T1 (el)
HU (1) HUE030042T2 (el)
IL (1) IL223753A (el)
JO (1) JO3196B1 (el)
LT (1) LT2612851T (el)
MA (1) MA35001B1 (el)
MD (1) MD4415C1 (el)
ME (1) ME02493B (el)
MX (1) MX2013000009A (el)
MY (1) MY160902A (el)
NI (1) NI201200195A (el)
PE (1) PE20131098A1 (el)
PH (1) PH12012000392A1 (el)
PL (1) PL2612851T3 (el)
PT (1) PT2612851T (el)
RS (1) RS55096B1 (el)
SA (1) SA113340172B1 (el)
SG (1) SG192337A1 (el)
SI (1) SI2612851T1 (el)
TN (1) TN2012000620A1 (el)
TW (1) TWI449693B (el)
UA (1) UA111333C2 (el)
UY (1) UY34553A (el)
WO (1) WO2013102740A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
TWI544987B (zh) 2015-10-27 2016-08-11 財團法人工業技術研究院 輕便型動力工具
EP3692520A4 (en) 2017-10-06 2021-07-28 Rad, Steve AUGMENTED REALITY SYSTEM AND KIT
US10430658B2 (en) 2017-10-06 2019-10-01 Steve Rad Augmented reality system and kit
CN110283104B (zh) * 2018-08-22 2022-06-14 南京济群医药科技股份有限公司 一种精氨酸培哚普利的制备方法
CN112047999B (zh) * 2020-09-18 2022-12-02 天津力生制药股份有限公司 一种γ晶型的精氨酸培哚普利盐的制备方法
CN114149357A (zh) * 2021-12-29 2022-03-08 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法
CN114894940A (zh) * 2022-06-02 2022-08-12 江苏嘉逸医药有限公司 一种高效液相色谱法测定精氨酸培哚普利中杂质的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
US7451943B2 (en) 2003-09-18 2008-11-18 Research Laboratories Of Australia Pty Ltd. Marking liquid method of preparation and product produced thereby
US7291745B2 (en) * 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP1864973A1 (en) * 2006-06-09 2007-12-12 Sochinaz SA Process for the preparation of perindopril and salts thereof
SI2318365T1 (sl) * 2008-06-24 2016-01-29 Mylan Laboratories Limited Nove polimorfne oblike perindopril (l) - arginina in postopek za pripravo
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23001A (sl) * 2009-03-20 2010-09-30 Diagen@d@o@o Nove soli perindoprila nov postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Also Published As

Publication number Publication date
GT201300002A (es) 2014-06-09
PH12012000392B1 (en) 2014-07-28
FR2985512A1 (fr) 2013-07-12
JP5722924B2 (ja) 2015-05-27
MA35001B1 (fr) 2014-04-03
BR102013000256B1 (pt) 2020-06-02
UY34553A (es) 2013-07-31
DK2612851T3 (en) 2016-10-03
ECSP13012366A (es) 2014-08-29
RS55096B1 (sr) 2016-12-30
TWI449693B (zh) 2014-08-21
CU20130003A7 (es) 2014-08-28
ES2595236T3 (es) 2016-12-28
KR20130080813A (ko) 2013-07-15
PH12012000392A1 (en) 2014-07-28
MD4415B1 (ro) 2016-04-30
US20130178635A1 (en) 2013-07-11
CU24293B1 (es) 2017-12-08
EP2612851B1 (fr) 2016-07-06
LT2612851T (lt) 2016-09-26
CL2013000022A1 (es) 2014-07-25
PL2612851T3 (pl) 2016-12-30
SA113340172B1 (ar) 2015-07-09
SG192337A1 (en) 2013-08-30
CA2801089C (fr) 2015-03-31
BR102013000256A2 (pt) 2013-12-03
SI2612851T1 (sl) 2016-11-30
AP2013006655A0 (en) 2013-01-31
WO2013102740A1 (fr) 2013-07-11
PE20131098A1 (es) 2013-10-12
CO6700138A1 (es) 2013-06-28
IL223753A0 (en) 2013-07-31
TW201332969A (zh) 2013-08-16
MD4415C1 (ro) 2016-11-30
KR101502946B1 (ko) 2015-03-16
AU2012268816B2 (en) 2014-12-11
CA2801089A1 (fr) 2013-07-05
US8865915B2 (en) 2014-10-21
MD20120129A2 (en) 2013-07-31
AU2012268816A1 (en) 2013-07-18
MX2013000009A (es) 2013-07-15
CN103193863A (zh) 2013-07-10
CN103193863B (zh) 2017-03-01
TN2012000620A1 (fr) 2014-04-01
AR089632A1 (es) 2014-09-03
EP2612851A1 (fr) 2013-07-10
CR20120654A (es) 2013-09-03
HRP20161145T1 (hr) 2016-11-18
JO3196B1 (ar) 2018-03-08
HUE030042T2 (en) 2017-04-28
JP2013139445A (ja) 2013-07-18
FR2985512B1 (fr) 2014-06-20
UA111333C2 (uk) 2016-04-25
ME02493B (me) 2017-02-20
PT2612851T (pt) 2016-08-01
GEP20146183B (en) 2014-10-27
EA201201667A1 (ru) 2013-09-30
EA022573B1 (ru) 2016-01-29
MY160902A (en) 2017-03-31
NI201200195A (es) 2013-06-03
IL223753A (en) 2015-08-31

Similar Documents

Publication Publication Date Title
CY1119345T1 (el) Μακροκυκλικες ενωσεις ως αναστολεις κινασης trk
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
PH12016500169A1 (en) Polymorph of syk inhibitors
CR20140042A (es) Indazoles
CR20150018A (es) Inhibidores macrocíclicos de virus flaviviridae
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
CR20130539A (es) Triazolopiridinas
CR20150061A (es) Compuesto de pirazolopirimidinas
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20120417A (es) Inhibidores de virus flaviviridae
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
UY33958A (es) Inhibidores de la glucosilceramida sintasa
CR20120637A (es) Triazolopiridinas sustituidas
AU2012213775A8 (en) 7-azaindole derivatives
UY34365A (es) Compuestos heterociclicos
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
UY33930A (es) Inhibidores novedosos de quinasas
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
BR112014009775A2 (pt) composição, método, semente e composto de fórmula 1
IN2014DN06192A (el)
CR20150006A (es) Metodo para preparar triazolopiridinas sustituidas
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
CR20150087A (es) Derivados de pirazol-carboxamida
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives